Results 121 to 130 of about 5,801,283 (182)

Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Chen CT, Chuang CH, Hsu CH, Shao YY.
europepmc   +1 more source

Plasma PIVKA-II levels in hepatobiliary disease.

Blood & Vessel, 1988
SUZUKI, Yuichi, NAKAO, Akimasa, ICHIHARA, Tohru, NONAMI, Toshiaki, HARADA, Akio, TAKAGI, Hiroshi   +5 more
openaire   +2 more sources

[Plasma PIVKA-II levels in various liver diseases--with special reference to plasma PIVKA-II as a marker of hepatocellular carcinoma].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1985
S, Fujiyama, A, Morishita, K, Yoshida, T, Harada, N, Oshima   +4 more
openaire   +3 more sources

Establishing a Decision-Making Threshold for PIVKA II in the Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC): A Single Centre Experience. [PDF]

Asian Pac J Cancer Prev
Farina A, Tartaglione S, Oliviero I, Viggiani V, Angeloni A, Anastasi E.   +5 more
europepmc   +1 more source

Erratum: Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma [Corrigendum]. [PDF]

J Hepatocell Carcinoma
europepmc   +1 more source

Immunohistochemical study of PIVKA-II in hepatocellular carcinoma.

Kanzo, 1990
NADANO, Seijin, TANIMOTO, Kenji, ONJI, Morikazu, MICHITAKA, Kojiro, HORIIKE, Norio, OHTA, Yasuyuki   +5 more
openaire   +2 more sources

⁶⁸Ga-FAPI-04 PET/CT in the Diagnosis of Hepatocellular Carcinoma Associated with Cirrhosis: Diagnostic Value, Correlation Between PET Parameters of the Tumor and Its Size, and PIVKA-II Levels. [PDF]

Diagnostics (Basel)
Zholdybay Z, Zhakenova Z, Issamatov B, Gabdullina M, Filippenko Y, Yessentayeva S, Alisherov G, Amankulov J, Fakhradiyev I.   +8 more
europepmc   +1 more source

Immunohistochemical study for PIVKA-II in hepatocellular carcinoma.

Kanzo, 1990
NOUNO, Ryuichi, YOSHITAKE, Masao, SAKISAKA, Shotaro, OGATA, Hideaki, MAJIMA, Yasuo, HIRAI, Kenji, TANIKAWA, Kyuichi   +6 more
openaire   +2 more sources

Combining AFP, PIVKA-II, and GP73 has diagnostic utility for hepatitis B-associated hepatocellular carcinoma and is consistent with liver pathology results. [PDF]

Sci Rep
Rui H, Yueqin N, Wei W, Bangtao L, Li X.
europepmc   +1 more source

Analysis of the optimal patterns of serum alpha fetoprotein (AFP), AFP-L3% and protein induced by vitamin K absence or antagonist-II (PIVKA-II) detection in the diagnosis of liver cancers. [PDF]

PeerJ
Luo L, Wang X, Peng X, Zhong R, Xuan X, Lin H, Lin X, Duan C.   +7 more
europepmc   +1 more source